These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interleukin-23 instructs protective multifunctional CD4 T cell responses after immunization with the Mycobacterium tuberculosis subunit vaccine H1 DDA/TDB independently of interleukin-17A. Ritter K; Behrends J; Erdmann H; Rousseau J; Hölscher A; Volz J; Prinz I; Lindenstrøm T; Hölscher C J Mol Med (Berl); 2021 Nov; 99(11):1585-1602. PubMed ID: 34351501 [TBL] [Abstract][Full Text] [Related]
3. The increased protection and pathology in Mycobacterium tuberculosis-infected IL-27R-alpha-deficient mice is supported by IL-17A and is associated with the IL-17A-induced expansion of multifunctional T cells. Erdmann H; Behrends J; Ritter K; Hölscher A; Volz J; Rosenkrands I; Hölscher C Mucosal Immunol; 2018 Jul; 11(4):1168-1180. PubMed ID: 29728641 [TBL] [Abstract][Full Text] [Related]
4. Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection. Gopal R; Monin L; Slight S; Uche U; Blanchard E; Fallert Junecko BA; Ramos-Payan R; Stallings CL; Reinhart TA; Kolls JK; Kaushal D; Nagarajan U; Rangel-Moreno J; Khader SA PLoS Pathog; 2014 May; 10(5):e1004099. PubMed ID: 24831696 [TBL] [Abstract][Full Text] [Related]
5. Mice genetically inactivated in interleukin-17A receptor are defective in long-term control of Mycobacterium tuberculosis infection. Freches D; Korf H; Denis O; Havaux X; Huygen K; Romano M Immunology; 2013 Oct; 140(2):220-31. PubMed ID: 23721367 [TBL] [Abstract][Full Text] [Related]
6. Involvement of IL-17A-producing TCR γδ T cells in late protective immunity against pulmonary Umemura M; Okamoto-Yoshida Y; Yahagi A; Touyama S; Nakae S; Iwakura Y; Matsuzaki G Immun Inflamm Dis; 2016 Dec; 4(4):401-412. PubMed ID: 27980775 [TBL] [Abstract][Full Text] [Related]
7. IL-17 Production of Neutrophils Enhances Antibacteria Ability but Promotes Arthritis Development During Mycobacterium tuberculosis Infection. Hu S; He W; Du X; Yang J; Wen Q; Zhong XP; Ma L EBioMedicine; 2017 Sep; 23():88-99. PubMed ID: 28821374 [TBL] [Abstract][Full Text] [Related]
8. Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization. Segueni N; Tritto E; Bourigault ML; Rose S; Erard F; Le Bert M; Jacobs M; Di Padova F; Stiehl DP; Moulin P; Brees D; Chibout SD; Ryffel B; Kammüller M; Quesniaux VF Sci Rep; 2016 Nov; 6():36923. PubMed ID: 27853279 [TBL] [Abstract][Full Text] [Related]
9. Novel role for IL-22 in protection during chronic Mycobacterium tuberculosis HN878 infection. Treerat P; Prince O; Cruz-Lagunas A; Muñoz-Torrico M; Salazar-Lezama MA; Selman M; Fallert-Junecko B; Reinhardt TA; Alcorn JF; Kaushal D; Zuñiga J; Rangel-Moreno J; Kolls JK; Khader SA Mucosal Immunol; 2017 Jul; 10(4):1069-1081. PubMed ID: 28247861 [TBL] [Abstract][Full Text] [Related]
10. Roles of interleukin-17 in an experimental Legionella pneumophila pneumonia model. Kimizuka Y; Kimura S; Saga T; Ishii M; Hasegawa N; Betsuyaku T; Iwakura Y; Tateda K; Yamaguchi K Infect Immun; 2012 Mar; 80(3):1121-7. PubMed ID: 22144493 [TBL] [Abstract][Full Text] [Related]
11. IL-22 is mainly produced by IFNγ-secreting cells but is dispensable for host protection against Mycobacterium tuberculosis infection. Behrends J; Renauld JC; Ehlers S; Hölscher C PLoS One; 2013; 8(2):e57379. PubMed ID: 23460846 [TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 4 signaling-mediated responses are critically engaged in optimal host protection against highly virulent Park J; Kim H; Kwon KW; Choi HH; Kang SM; Hong JJ; Shin SJ Virulence; 2020 Dec; 11(1):430-445. PubMed ID: 32403973 [TBL] [Abstract][Full Text] [Related]
13. Increased pulmonary tumor necrosis factor alpha, interleukin-6 (IL-6), and IL-17A responses compensate for decreased gamma interferon production in anti-IL-12 autovaccine-treated, Mycobacterium bovis BCG-vaccinated mice. Freches D; Romano M; Korf H; Renauld JC; Van Snick J; Uyttenhove C; Huygen K Clin Vaccine Immunol; 2011 Jan; 18(1):95-104. PubMed ID: 21084465 [TBL] [Abstract][Full Text] [Related]
14. Ficolin-2 defends against virulent Mycobacteria tuberculosis infection in vivo, and its insufficiency is associated with infection in humans. Luo F; Sun X; Wang Y; Wang Q; Wu Y; Pan Q; Fang C; Zhang XL PLoS One; 2013; 8(9):e73859. PubMed ID: 24040095 [TBL] [Abstract][Full Text] [Related]
15. Th17-related cytokines contribute to recall-like expansion/effector function of HMBPP-specific Vγ2Vδ2 T cells after Mycobacterium tuberculosis infection or vaccination. Shen H; Wang Y; Chen CY; Frencher J; Huang D; Yang E; Ryan-Payseur B; Chen ZW Eur J Immunol; 2015 Feb; 45(2):442-51. PubMed ID: 25141829 [TBL] [Abstract][Full Text] [Related]
16. Distinct contributions of the innate immune receptors TLR2 and RP105 to formation and architecture of structured lung granulomas in mice infected with Mycobacterium tuberculosis. Donovan ML; Bielefeldt-Ohmann H; Rollo RF; McPherson SJ; Schultz TE; Mori G; Kling JC; Blumenthal A Immunology; 2023 May; 169(1):13-26. PubMed ID: 36370035 [TBL] [Abstract][Full Text] [Related]
19. Interleukin 24 as a novel potential cytokine immunotherapy for the treatment of Mycobacterium tuberculosis infection. Ma Y; Chen HD; Wang Y; Wang Q; Li Y; Zhao Y; Zhang XL Microbes Infect; 2011 Nov; 13(12-13):1099-110. PubMed ID: 21787878 [TBL] [Abstract][Full Text] [Related]
20. Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. Okamoto Yoshida Y; Umemura M; Yahagi A; O'Brien RL; Ikuta K; Kishihara K; Hara H; Nakae S; Iwakura Y; Matsuzaki G J Immunol; 2010 Apr; 184(8):4414-22. PubMed ID: 20212094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]